BPC-157 10mg · Research brief

Is It Legal to Sell Peptides? Federal Rules Explained

Real Peptides Research TeamEditorial

Updated September 29, 20268 min read

55 WORDS

Short answer

The legality of a peptide almost never depends on the molecule. It depends on what you say about it. Two companies can ship an identical vial from an identical synthesis lot at identical purity. One is running a lawful research supply business, the other is distributing an unapproved new drug, and the difference is wording.

Key takeaways

Peptide legality is determined by intended use under 21 U.S.C. § 321(g)(1), not by the molecule, so identical vials can be lawful reagents or unapproved new drugs.
Research-use-only labeling originates in in vitro diagnostic regulation at 21 CFR 809.10(c)(2)(i) and works only when distribution practice genuinely matches the label.
21 CFR 201.128 lets regulators infer intended use from advertising, representatives' statements and a firm's knowledge of how buyers actually use a product.
Section 352(f) misbranding means there is no lawful way to publish directions for use for a compound with no approved indication.
FDA has placed several popular peptides in Category 2 of its 503A bulk drug substances review, which restricts what compounding pharmacies may prepare.
Lot-specific certificates of analysis with HPLC purity and mass spectrometry identity are the single clearest signal separating a real supplier from a repackager.

We supply research-grade peptides to laboratories and independent researchers, so we work inside these rules constantly. So is it legal to sell peptides? Yes, under conditions that most new sellers discover only after a warning letter arrives.

Is it legal to sell peptides?

Yes, selling peptides is legal when they are supplied and labeled strictly as research-use-only chemicals with no human-use claims. Federal law regulates intended use, not chemistry, so the same vial becomes an unapproved new drug under 21 U.S.C. § 355 the moment a seller suggests a therapeutic or body-altering purpose.

The common misreading is that a 'Not for human consumption' disclaimer settles the question. It doesn't. Under 21 CFR 201.128, regulators can establish intended use from circumstances, including what a seller knows buyers actually do with a product. This article covers the federal statutes that apply, what research-use-only labeling legally means, and the operational steps that keep an online peptide business on the right side of that line.

Is it legal to sell peptides under federal law?

Yes, but the permission comes from an absence rather than a license. Peptides that aren't scheduled controlled substances and aren't sold with drug claims simply aren't regulated as drugs, which is why no federal peptide seller's license exists for anyone to apply for.

The Federal Food, Drug, and Cosmetic Act (FDCA) defines a drug at 21 U.S.C. § 321(g)(1) by intended use: any article intended for the diagnosis, cure, mitigation, treatment or prevention of disease, or intended to affect the structure or any function of the body. Chemistry is irrelevant to that definition. A vial of a peptide sold to a university lab studying tendon fibroblasts is a laboratory reagent. The same vial sold alongside copy about healing an injury is an unapproved new drug, and introducing it into interstate commerce violates 21 U.S.C. § 331(a) and § 355.

Misbranding creates a second exposure. Section 352(f) requires adequate directions for use, which no seller can lawfully supply for a compound with no approved indication. There is no compliant way to add usage instructions, which is precisely why legitimate suppliers don't.

Dietary supplement framing is closed too. 21 U.S.C. § 321(ff)(3)(B)(ii) excludes any article authorized for investigation as a new drug where substantial clinical investigations were instituted and made public.

So is selling peptides online illegal? Not inherently. Selling them for human use without approval is. In our experience, most sellers who receive letters never changed their product at all. They changed their marketing.

What 'research use only' actually means on a label

Research use only is a labeling category borrowed from in vitro diagnostic regulation, not a blanket exemption for chemicals. The exact phrase 'For Research Use Only. Not for use in diagnostic procedures.' traces to 21 CFR 809.10(c)(2)(i), and it functions by signalling that a product sits in a laboratory phase of investigation and is not offered for clinical or personal use.

That distinction matters because RUO status describes how a product is genuinely distributed. It is not a magic phrase. Under 21 CFR 201.128, intended use may be established from labeling, advertising, oral or written statements by a firm or its representatives, and the circumstances in which an article is offered, including a firm's knowledge that buyers use it for an unlabeled purpose.

Here's the mistake almost nobody warns new sellers about: the label is rarely what fails. The support inbox is. A single reply telling a customer how much to reconstitute or how often to use something converts an entire catalog into evidence of intended use, retroactively, across every order already shipped. The same logic applies to bundling a vial with bacteriostatic water and syringes at checkout, to affiliate articles carrying before-and-after photos, and to product categories named after body-composition goals rather than research targets.

Our team reviews copy against this standard constantly, and the pattern repeats: legal risk enters through the parts of a website nobody thinks of as marketing.

How can I legally sell peptides online?

Any registered business can supply research chemicals, so can anyone sell peptides online? Technically yes, and that is exactly why the market is so uneven. No federal license gates entry for non-scheduled compounds, which puts the entire compliance burden on operating discipline rather than paperwork.

What that discipline looks like in practice:

Sell to research buyers only, with terms of sale that state it and a checkout that doesn't contradict it.
Lot-specific certificates of analysis showing identity by mass spectrometry and purity by HPLC, tied to the lot number on the vial in the box.
Labeling that carries lot number, net quantity, storage conditions and the RUO statement, and carries no directions for use.
Zero human-use claims across product pages, paid ads, email, social accounts and affiliate partners.
Business registration and tax compliance, plus a check on state-level substance rules, which sometimes reach further than the federal list.
Import and shipping documentation, since raw peptide material frequently crosses borders and is subject to screening.
Cold chain records: lyophilised peptides are typically held frozen near -20°C, and reconstituted material is typically refrigerated at 2-8°C, so storage claims need evidence behind them.

Is it legal to sell peptides online in the US as research material? Yes, and that is how legitimate suppliers operate. As a treatment? No, unless you are an approved manufacturer or a licensed pharmacy dispensing against valid prescriptions. This is education, not legal advice: have a regulatory attorney review your copy, and if your question involves an animal, talk to your veterinarian, because only a licensed vet can make treatment decisions for one.

Who can sell peptides online, and under what authority

Different seller types operate under completely different legal authority, and conflating them is how businesses end up exposed. This table maps each route, what it permits, and where each one typically breaks.

Seller type	What they can lawfully offer	Authorisation required	Most common failure point	Bottom line
Research-use-only supplier	Non-scheduled peptides sold as laboratory reagents with per-lot certificates of analysis	Business registration only, since no drug claim is made and no drug is being introduced	Marketing copy, support replies or affiliate content that implies personal use	Lawful and sustainable as long as intended-use discipline holds at every customer touchpoint
503A compounding pharmacy	Patient-specific preparations dispensed against a valid prescription	State pharmacy licensure, a prescriber relationship, and FDCA § 503A conditions on bulk substances	Using bulk substances FDA has placed in Category 2 of its 503A review, BPC-157 among them	Legitimate for prescription dispensing, but the eligible peptide list is far narrower than most clinics assume
503B outsourcing facility	Office-stock sterile preparations without patient-specific prescriptions	FDA registration, cGMP compliance and adverse event reporting obligations	Compounding something that is essentially a copy of an approved drug product	The only realistic volume route into clinic supply, with manufacturing obligations to match
Dietary supplement brand	Ingredients that genuinely qualify as dietary ingredients under DSHEA	Facility registration, supplement cGMP, and substantiation for structure/function claims	The exclusion at 21 U.S.C. § 321(ff)(3)(B)(ii) that removes drug-investigated articles	Rarely a viable pathway for peptides, because the door closes before any marketing begins
Offshore or grey-market reseller	Very little that survives a compliance review intact	None claimed, and usually none held	Missing COAs, open human-use claims, and import screening on inbound parcels	The lower price reflects the testing that wasn't done and the legal risk transferred to the buyer

What If: Real Situations Peptide Sellers Run Into

What if a customer asks me how much to use?

Decline in writing, every time, and point them back to the research-use-only terms of sale. Under 21 CFR 201.128, oral or written statements by a firm or its representatives establish intended use, so a single helpful reply becomes evidence that the product was offered for human use. Train whoever answers the inbox before you take the first order, because that message is stored, forwarded and screenshotted.

What if I buy in bulk and relabel under my own brand?

Insist on a certificate of analysis matched to the exact lot you received, not a generic sample document. Relabelling makes you the responsible party for identity and purity, and a COA from a different lot proves nothing about the vials in your warehouse. Verify that the lot number on the certificate matches the lot number printed on the vial, and keep the chain of custody documented from synthesis to shipment.

What if I want to sell to buyers in another country?

Check the destination country's import rules before you list anything, because research chemical classifications vary widely and parcels get screened at entry. Some jurisdictions treat peptides as prescription-only medicines regardless of RUO labeling, which makes the buyer, and sometimes the shipper, liable. Customs seizures also generate records that travel back to the sending business.

What if a regulator contacts me about a product page?

Stop shipping the affected SKU, preserve every version of the page and the related emails, and get regulatory counsel before you reply. Warning letters typically quote specific claims, so the fastest remediation is removing the claim language and documenting the correction rather than arguing chemistry. Deleting pages without preserving copies makes the response harder, not easier.

The Uncomfortable Truth About Grey-Market Peptide Sales

Here's the honest answer: a large share of online peptide sellers know exactly who their buyers are and what they intend to do, and the RUO label is being used as a costume rather than a description. That gap is what draws enforcement attention, and it is also what drives the quality problem, because a seller optimising for personal-use buyers has no reason to pay for per-lot testing. Purity verification costs money and never appears in a customer photo. Legitimate research supply is a documentation business first and a chemistry business second.

Everything we ship is built around that principle. Lot-specific certificates of analysis are published at our COA library, the current research catalog is at our shop, and facility and shipping details are available on our location page for laboratories that need them for procurement records.

Ask is it legal to sell peptides and the honest answer is that the molecule was never the regulated thing. The claim was. Regulators have spent decades building a framework that hinges on a single question: what did you intend this product to do, and what did you tell people it would do? Sellers who internalise that build businesses that survive scrutiny, publish real data, and attract researchers who check certificates. Sellers who treat the disclaimer as a costume eventually meet the difference between labeling and practice, usually in writing, on official letterhead.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add vials.

Start a pack

Questions

Yes, selling peptides is legal when they are offered strictly as research-use-only laboratory materials with no human-use claims. Federal drug status under 21 U.S.C. § 321(g)(1) is determined by intended use rather than chemistry, so identical vials can be lawful reagents or unapproved new drugs depending entirely on how they are marketed and sold.

Register a business, source material with lot-specific certificates of analysis, label every vial as research use only with no directions for use, and remove every human-use claim from product pages, ads, email and affiliate content. Restrict sales to research buyers in your terms, document storage and shipping, and have a regulatory attorney review all copy.

Yes, selling peptides online is legal under the same conditions that apply offline, because the sales channel doesn't change the legal analysis. Websites simply create the largest exposure, since product copy, ads and support emails are archived, indexed and easy for regulators to review long after a page is changed or deleted.

Only when the seller crosses into drug territory. Offering a peptide with claims that it treats a condition or alters body structure or function makes it an unapproved new drug, and introducing that into interstate commerce violates 21 U.S.C. § 331(a) and § 355. Research supply without claims is not illegal.

Yes, provided you sell non-scheduled compounds as research materials, publish lot-matched certificates of analysis, and make no human-use claims anywhere in your marketing or customer communication. You also need standard business registration, tax compliance, and a check on state rules that sometimes cover substances beyond the federal list.

Practically, yes, and that is the core problem with the market. No federal license gates entry for non-scheduled research chemicals, so quality and compliance vary enormously between suppliers. The absence of a licensing requirement shifts the burden onto buyers to verify testing documentation, lot traceability and claim-free marketing before ordering.

Yes, when the peptides are non-scheduled, sold as research-use-only reagents, and marketed without any therapeutic or performance claims. The legal exposure comes from marketing language rather than the transaction itself. Selling the same compounds for personal use without drug approval or a pharmacy license is a federal violation.

Research-use-only suppliers can sell non-scheduled peptides as laboratory reagents, 503A pharmacies can compound patient-specific preparations against prescriptions, and 503B outsourcing facilities can supply office stock under FDA registration and cGMP. Each route carries different authorisation requirements, and none of them permits general consumer sales with treatment claims.

No, that is where RUO labeling stops protecting the seller. 21 CFR 201.128 allows intended use to be established from the circumstances of offering, including a firm's knowledge that buyers use a product for an unlabeled purpose. Copy, imagery, bundled supplies and support replies all become evidence.

A useful certificate names the specific lot, reports identity confirmation by mass spectrometry, reports purity by HPLC with the chromatogram included, and states the test date and testing party. A generic PDF with no lot number matching the vial in your hand demonstrates nothing about the material you received.

Research-grade peptides are laboratory reagents supplied without drug claims and without prescriptions, verified by certificate of analysis. Compounded peptides are prescription preparations made by licensed pharmacies for identified patients under FDCA § 503A conditions, including restrictions on which bulk substances may be used. The regulatory pathway differs completely, not the chemistry alone.

Costs vary widely by scale and jurisdiction, but the recurring line items are predictable: third-party HPLC and mass spectrometry testing for every lot, cold storage and validated shipping, product liability insurance, business and tax registration, and regulatory review of website copy. Per-lot testing is usually the largest ongoing expense.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA